It marked our 21st week of tracking our cumulative Rocket Stock performance, now up to 45.21% outperformance over the
, our perennial benchmark, which gained 0.04% in the last five trading sessions.
Stocks are pointed higher this morning after a
$10 billion bailout
from Abu Dhabi eased concerns about Dubai's debt crisis. The move saves private government interest Dubai World from defaulting on a bond issue set to expire today, and it reassures investors who were considering investment in the emirate.
While we have yet to make any Dubai plays in our weekly Rocket Stocks list, which takes a look at beaten-down stocks with near-term growth catalysts and long-term growth potential, we can take advantage of the uptick Dubai's rescue is sure to mean for stocks across the board this week.
was pharmaceutical stock
, which gained 2.95% following a Thursday morning analyst upgrade. The company was trailed by
the medical supply company that gained 1.74% on the week, and
, which brought in 0.97%. Faring lower last week were
, which slid 2.35% and 2.22% -- bringing our average gain to 0.42% on the week.
Now, let's take a look at
Jumbo-sized electronics retailer
has benefitted in a big way by seeing its top competitor, Circuit City, close up shop this year, bringing the company's reach to 6% of the $700 billion global electronics market.
But seeing Circuit City go hasn't meant that competition got any less challenging in 2009, as macroeconomic trends and increased pressure from the likes of
squeezed sales in a big way.
Who Owns Best Buy?
Investors still seem to think that Best Buy is a buy, though. They've pushed shares 58% higher year-to-date amid the still-strong global rally. And analysts continue to praise Best Buy for strong demographics and well-positioned product offerings. With earnings slated for Tuesday, the company could be on the verge of a catalyst higher right now.
While retail segments across the board have taken hits in the last year, one that's proved relatively recession resistant is cereal.
People have cut back in other areas, but they've apparently opted to keep eating their preferred brands, a very good thing for cereal companies such as
, which controls brands such as Cheerios alongside noncereal names such as Pillsbury and Progresso Soup.
Thick margins and still-strong demand has helped General Mills stay ahead of the curve during the recession, even if it stayed one step behind competitor
in the cereal category. General Mills is a cash machine, generating $1.3 billion in free cash flow for fiscal 2009, a number that's approximately 10% of sales. We'll get our next glimpse at General Mills' financials on Dec. 17 when the company reports its second-quarter 2010 earnings before the market opens.
Healthcare product maker
has had a strong showing among investors this year, pushing up 30% since this past January.
Covidien operates in three segments: medical devices, medical supplies and pharmaceuticals. The company has its hand in high-growth medical niches, including bariatric surgery products, the fruits of heavy research-and-development spending over the last few years.
That R&D spending has afforded Covidien relatively strong barriers to entry in the medical field, something that's particularly important as health care continues to be legislated on capital hill.
For more stocks that made this week's cut, including
, check out the
-- Written by Jonas Elmerraji in Baltimore.
At the time of publication, author had no position in stocks mentioned.
Jonas Elmerraji, based out of Baltimore, is the editor and portfolio manager of the Rhino Stock Report, a free investment advisory that returned 15% in 2008. He is a contributor to numerous financial outlets, including Forbes and Investopedia, and has been featured in Investor's Business Daily, in Consumer's Digest and on MSNBC.com.